358 related articles for article (PubMed ID: 21723381)
1. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
Wang Y; Wang J; Gao L; Stamm S; Andreadis A
Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.
Wang Y; Gao L; Tse SW; Andreadis A
Gene; 2010 Feb; 451(1-2):23-31. PubMed ID: 19914360
[TBL] [Abstract][Full Text] [Related]
3. SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations.
Gao L; Wang J; Wang Y; Andreadis A
Mol Cell Neurosci; 2007 Jan; 34(1):48-58. PubMed ID: 17137791
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous nuclear ribonucleoprotein E2 binds to tau exon 10 and moderately activates its splicing.
Broderick J; Wang J; Andreadis A
Gene; 2004 Apr; 331():107-14. PubMed ID: 15094196
[TBL] [Abstract][Full Text] [Related]
5. Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c.SRp55 complex that either recruits or antagonizes htra2beta1.
Wang Y; Wang J; Gao L; Lafyatis R; Stamm S; Andreadis A
J Biol Chem; 2005 Apr; 280(14):14230-9. PubMed ID: 15695522
[TBL] [Abstract][Full Text] [Related]
6. Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors.
Wang J; Gao QS; Wang Y; Lafyatis R; Stamm S; Andreadis A
J Neurochem; 2004 Mar; 88(5):1078-90. PubMed ID: 15009664
[TBL] [Abstract][Full Text] [Related]
7. Regulation of alternative splicing of tau exon 10.
Qian W; Liu F
Neurosci Bull; 2014 Apr; 30(2):367-77. PubMed ID: 24627328
[TBL] [Abstract][Full Text] [Related]
8. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.
Gu J; Chen F; Iqbal K; Gong CX; Wang X; Liu F
J Biol Chem; 2017 Jun; 292(25):10600-10612. PubMed ID: 28487370
[TBL] [Abstract][Full Text] [Related]
9. PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.
Ray P; Kar A; Fushimi K; Havlioglu N; Chen X; Wu JY
J Mol Neurosci; 2011 Nov; 45(3):453-66. PubMed ID: 21881826
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies.
Rodriguez-Martin T; Garcia-Blanco MA; Mansfield SG; Grover AC; Hutton M; Yu Q; Zhou J; Anderton BH; Gallo JM
Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15659-64. PubMed ID: 16230627
[TBL] [Abstract][Full Text] [Related]
11. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10.
Yu Q; Guo J; Zhou J
J Neurochem; 2004 Jul; 90(1):164-72. PubMed ID: 15198676
[TBL] [Abstract][Full Text] [Related]
12. Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K.
D'Souza I; Schellenberg GD
J Biol Chem; 2006 Feb; 281(5):2460-9. PubMed ID: 16308321
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.
Zhou J; Yu Q; Zou T
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S10. PubMed ID: 19090983
[TBL] [Abstract][Full Text] [Related]
14. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion.
Yin X; Jin N; Gu J; Shi J; Zhou J; Gong CX; Iqbal K; Grundke-Iqbal I; Liu F
J Biol Chem; 2012 Aug; 287(36):30497-506. PubMed ID: 22767602
[TBL] [Abstract][Full Text] [Related]
15. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17.
Jiang Z; Cote J; Kwon JM; Goate AM; Wu JY
Mol Cell Biol; 2000 Jun; 20(11):4036-48. PubMed ID: 10805746
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of tau isoform transcripts in sporadic tauopathies.
Connell JW; Rodriguez-Martin T; Gibb GM; Kahn NM; Grierson AJ; Hanger DP; Revesz T; Lantos PL; Anderton BH; Gallo JM
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):104-9. PubMed ID: 15950767
[TBL] [Abstract][Full Text] [Related]
17. Tau alternative splicing in familial and sporadic tauopathies.
Niblock M; Gallo JM
Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715
[TBL] [Abstract][Full Text] [Related]
18. Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.
Kalbfuss B; Mabon SA; Misteli T
J Biol Chem; 2001 Nov; 276(46):42986-93. PubMed ID: 11560926
[TBL] [Abstract][Full Text] [Related]
19. Neurodegenerative disorder FTDP-17-related tau intron 10 +16C → T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice.
Umeda T; Yamashita T; Kimura T; Ohnishi K; Takuma H; Ozeki T; Takashima A; Tomiyama T; Mori H
Am J Pathol; 2013 Jul; 183(1):211-25. PubMed ID: 23680655
[TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease.
Shi J; Qian W; Yin X; Iqbal K; Grundke-Iqbal I; Gu X; Ding F; Gong CX; Liu F
J Biol Chem; 2011 Apr; 286(16):14639-48. PubMed ID: 21367856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
